PRO-C3-levels in patients with HIV/HCV-Co-infection reflect fibrosis stage and degree of portal hypertension.
<h4>Background</h4>Liver-related deaths represent the leading cause of mortality among patients with HIV/HCV-co-infection, and are mainly related to complications of fibrosis and portal hypertension. In this study, we aimed to evaluate the structural changes by the assessment of extracel...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2014
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/5ccb18101b9e4197bd1a89a1c67ebc58 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:5ccb18101b9e4197bd1a89a1c67ebc58 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:5ccb18101b9e4197bd1a89a1c67ebc582021-11-25T05:58:49ZPRO-C3-levels in patients with HIV/HCV-Co-infection reflect fibrosis stage and degree of portal hypertension.1932-620310.1371/journal.pone.0108544https://doaj.org/article/5ccb18101b9e4197bd1a89a1c67ebc582014-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0108544https://doaj.org/toc/1932-6203<h4>Background</h4>Liver-related deaths represent the leading cause of mortality among patients with HIV/HCV-co-infection, and are mainly related to complications of fibrosis and portal hypertension. In this study, we aimed to evaluate the structural changes by the assessment of extracellular matrix (ECM) derived degradation fragments in peripheral blood as biomarkers for fibrosis and portal hypertension in patients with HIV/HCV co-infection.<h4>Methods</h4>Fifty-eight patients (67% male, mean age: 36.5 years) with HIV/HCV-co-infection were included in the study. Hepatic venous pressure gradient (HVPG) was measured in forty-three patients. The fibrosis stage was determined using FIB4 -Score. ECM degraded products in peripheral blood were measured using specific ELISAs (C4M, MMP-2/9 degraded type IV collagen; C5M, MMP-2/9 degraded type V collagen; PRO-C3, MMP degraded n-terminal propeptide of type III collagen).<h4>Results</h4>As expected, HVPG showed strong and significant correlations with FIB4-index (rs = 0.628; p = 7*10-7). Interestingly, PRO-C3 significantly correlated with HVPG (rs = 0.354; p = 0.02), alanine aminotransferase (rs = 0.30; p = 0.038), as well as with FIB4-index (rs = 0.3230; p = 0.035). C4M and C5M levels were higher in patients with portal hypertension (HVPG>5 mmHg).<h4>Conclusion</h4>PRO-C3 levels reflect liver injury, stage of liver fibrosis and degree of portal hypertension in HIV/HCV-co-infected patients. Furthermore, C4M and C5M were associated with increased portal pressure. Circulating markers of hepatic ECM remodeling might be helpful in the diagnosis and management of liver disease and portal hypertension in patients with HIV/HCV coinfection.Christian JansenDiana J LeemingMattias MandorferInger ByrjalsenRobert SchierwagenPhilipp SchwablMorten A KarsdalEvrim AnadolChristian P StrassburgJürgen RockstrohMarkus Peck-RadosavljevicSøren MøllerFlemming BendtsenAleksander KragThomas ReibergerJonel TrebickaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 9, p e108544 (2014) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Christian Jansen Diana J Leeming Mattias Mandorfer Inger Byrjalsen Robert Schierwagen Philipp Schwabl Morten A Karsdal Evrim Anadol Christian P Strassburg Jürgen Rockstroh Markus Peck-Radosavljevic Søren Møller Flemming Bendtsen Aleksander Krag Thomas Reiberger Jonel Trebicka PRO-C3-levels in patients with HIV/HCV-Co-infection reflect fibrosis stage and degree of portal hypertension. |
| description |
<h4>Background</h4>Liver-related deaths represent the leading cause of mortality among patients with HIV/HCV-co-infection, and are mainly related to complications of fibrosis and portal hypertension. In this study, we aimed to evaluate the structural changes by the assessment of extracellular matrix (ECM) derived degradation fragments in peripheral blood as biomarkers for fibrosis and portal hypertension in patients with HIV/HCV co-infection.<h4>Methods</h4>Fifty-eight patients (67% male, mean age: 36.5 years) with HIV/HCV-co-infection were included in the study. Hepatic venous pressure gradient (HVPG) was measured in forty-three patients. The fibrosis stage was determined using FIB4 -Score. ECM degraded products in peripheral blood were measured using specific ELISAs (C4M, MMP-2/9 degraded type IV collagen; C5M, MMP-2/9 degraded type V collagen; PRO-C3, MMP degraded n-terminal propeptide of type III collagen).<h4>Results</h4>As expected, HVPG showed strong and significant correlations with FIB4-index (rs = 0.628; p = 7*10-7). Interestingly, PRO-C3 significantly correlated with HVPG (rs = 0.354; p = 0.02), alanine aminotransferase (rs = 0.30; p = 0.038), as well as with FIB4-index (rs = 0.3230; p = 0.035). C4M and C5M levels were higher in patients with portal hypertension (HVPG>5 mmHg).<h4>Conclusion</h4>PRO-C3 levels reflect liver injury, stage of liver fibrosis and degree of portal hypertension in HIV/HCV-co-infected patients. Furthermore, C4M and C5M were associated with increased portal pressure. Circulating markers of hepatic ECM remodeling might be helpful in the diagnosis and management of liver disease and portal hypertension in patients with HIV/HCV coinfection. |
| format |
article |
| author |
Christian Jansen Diana J Leeming Mattias Mandorfer Inger Byrjalsen Robert Schierwagen Philipp Schwabl Morten A Karsdal Evrim Anadol Christian P Strassburg Jürgen Rockstroh Markus Peck-Radosavljevic Søren Møller Flemming Bendtsen Aleksander Krag Thomas Reiberger Jonel Trebicka |
| author_facet |
Christian Jansen Diana J Leeming Mattias Mandorfer Inger Byrjalsen Robert Schierwagen Philipp Schwabl Morten A Karsdal Evrim Anadol Christian P Strassburg Jürgen Rockstroh Markus Peck-Radosavljevic Søren Møller Flemming Bendtsen Aleksander Krag Thomas Reiberger Jonel Trebicka |
| author_sort |
Christian Jansen |
| title |
PRO-C3-levels in patients with HIV/HCV-Co-infection reflect fibrosis stage and degree of portal hypertension. |
| title_short |
PRO-C3-levels in patients with HIV/HCV-Co-infection reflect fibrosis stage and degree of portal hypertension. |
| title_full |
PRO-C3-levels in patients with HIV/HCV-Co-infection reflect fibrosis stage and degree of portal hypertension. |
| title_fullStr |
PRO-C3-levels in patients with HIV/HCV-Co-infection reflect fibrosis stage and degree of portal hypertension. |
| title_full_unstemmed |
PRO-C3-levels in patients with HIV/HCV-Co-infection reflect fibrosis stage and degree of portal hypertension. |
| title_sort |
pro-c3-levels in patients with hiv/hcv-co-infection reflect fibrosis stage and degree of portal hypertension. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2014 |
| url |
https://doaj.org/article/5ccb18101b9e4197bd1a89a1c67ebc58 |
| work_keys_str_mv |
AT christianjansen proc3levelsinpatientswithhivhcvcoinfectionreflectfibrosisstageanddegreeofportalhypertension AT dianajleeming proc3levelsinpatientswithhivhcvcoinfectionreflectfibrosisstageanddegreeofportalhypertension AT mattiasmandorfer proc3levelsinpatientswithhivhcvcoinfectionreflectfibrosisstageanddegreeofportalhypertension AT ingerbyrjalsen proc3levelsinpatientswithhivhcvcoinfectionreflectfibrosisstageanddegreeofportalhypertension AT robertschierwagen proc3levelsinpatientswithhivhcvcoinfectionreflectfibrosisstageanddegreeofportalhypertension AT philippschwabl proc3levelsinpatientswithhivhcvcoinfectionreflectfibrosisstageanddegreeofportalhypertension AT mortenakarsdal proc3levelsinpatientswithhivhcvcoinfectionreflectfibrosisstageanddegreeofportalhypertension AT evrimanadol proc3levelsinpatientswithhivhcvcoinfectionreflectfibrosisstageanddegreeofportalhypertension AT christianpstrassburg proc3levelsinpatientswithhivhcvcoinfectionreflectfibrosisstageanddegreeofportalhypertension AT jurgenrockstroh proc3levelsinpatientswithhivhcvcoinfectionreflectfibrosisstageanddegreeofportalhypertension AT markuspeckradosavljevic proc3levelsinpatientswithhivhcvcoinfectionreflectfibrosisstageanddegreeofportalhypertension AT sørenmøller proc3levelsinpatientswithhivhcvcoinfectionreflectfibrosisstageanddegreeofportalhypertension AT flemmingbendtsen proc3levelsinpatientswithhivhcvcoinfectionreflectfibrosisstageanddegreeofportalhypertension AT aleksanderkrag proc3levelsinpatientswithhivhcvcoinfectionreflectfibrosisstageanddegreeofportalhypertension AT thomasreiberger proc3levelsinpatientswithhivhcvcoinfectionreflectfibrosisstageanddegreeofportalhypertension AT joneltrebicka proc3levelsinpatientswithhivhcvcoinfectionreflectfibrosisstageanddegreeofportalhypertension |
| _version_ |
1718414340272422912 |